NeoGenomics
(NASDAQ) NEO
NeoGenomics Financials at a Glance
Market Cap
$1.04B
Revenue (TTM)
$727.33M
Net Income (TTM)
$108.03M
EPS (TTM)
$-0.84
P/E Ratio
-9.48
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$7.99
Volume
57,452
Open
$7.64
Price
$7.99
Volume
57,452
Open
$7.64
Previous Close
$7.99
Daily Range
$7.26 - $8.00
52-Week Range
$4.72 - $13.74
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$7.99
Volume
57,452
Open
$7.64
Previous Close
$7.99
Daily Range
$7.26 - $8.00
52-Week Range
$4.72 - $13.74
NEO News
NEO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NeoGenomics
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
2,500
CEO
Anthony P. Zook
Website
www.neogenomics.comHeadquarters
Fort Myers, FL 33912, US
NEO Financials
Key Financial Metrics (TTM)
Gross Margin
42%
Operating Margin
-16%
Net Income Margin
-15%
Return on Equity
-12%
Return on Capital
-9%
Return on Assets
-8%
Earnings Yield
-10.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.04B
Shares Outstanding
129.81M
Volume
57.45K
Short Interest
0.00%
Avg. Volume
1.87M
Financials (TTM)
Gross Profit
$282.54M
Operating Income
$66.08M
EBITDA
$1.75M
Operating Cash Flow
$5.23M
Capital Expenditure
$27.01M
Free Cash Flow
$21.78M
Cash & ST Invst.
$159.62M
Total Debt
$472.28M
NeoGenomics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$190.17M
+10.6%
Gross Profit
$75.71M
-2.0%
Gross Margin
39.81%
N/A
Market Cap
$1.04B
N/A
Market Cap/Employee
$472.04K
N/A
Employees
2,200
N/A
Net Income
$9.88M
+35.5%
EBITDA
$5.25M
+42.6%
Quarterly Fundamentals
Net Cash
$312.66M
-43.1%
Accounts Receivable
$159.24M
+5.8%
Inventory
$28.57M
+6.8%
Long Term Debt
$467.50M
+16.5%
Short Term Debt
$4.78M
-97.7%
Return on Assets
-7.94%
N/A
Return on Invested Capital
-8.93%
N/A
Free Cash Flow
$6.53M
-262.9%
Operating Cash Flow
$1.34M
-86.3%